GlassScriptPhysician profile
Hiren K Patel
NPI 1568481661
$4,212.40
in general payments reported to CMS, 2019-2025
39 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $381 · 2021: $427 · 2022: $494 · 2023: $797 · 2024: $797 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,620.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $957.21 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $521.78 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $216.53 | 2019-2025 | |
| Amarin Pharma, INC. | $203.56 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.44 | 2020-2025 | Xifaxan |
| Amgen INC. | $181.12 | 2019-2024 | Repatha, Otezla |
| Lilly USA, LLC | $178.23 | 2019-2024 | Mounjaro |
| Neurocrine Biosciences, INC. | $159.68 | 2023-2024 | Ingrezza |
| Novo Nordisk INC | $158.37 | 2019-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $144.25 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $143.46 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $107.55 | 2023-2025 | Austedo Xr, Austedo Xr |
| Inspire Medical Systems, INC. | $95.98 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $95.23 | 2023-2025 | Rexulti |
| Daiichi Sankyo INC. | $77.64 | 2022-2025 | Enhertu, Injectafer |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hiren Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.